Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sertraline
- Therapeutic area
- CNS & mental health
- Drug class
- SSRI antidepressants
- ATC
- N06A
- Strength
- 50 mg
- Dosage form
- Tablet
- Pack
- 3 x 10's
- Registration no.
- 104307
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-11-18 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Palsiwan (Sertraline) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Sertraline is right for you and the dose.
- Anxiety disorders: first choice of medicine for most anxiety disorders, including generalised anxiety disorder and panic disorder
- Depression: usual first choice of antidepressant for moderate or severe depression
- Irritable bowel syndrome (IBS): Considered only if a tricyclic antidepressant has not worked
About Palsiwan 50 mg tablet
Palsiwan 50 mg tablet contains Sertraline 50 mg. It is registered with DRAP by Nawan Laboratories Pvt Ltd (registration no. 104307). Its official price is PKR 1,539.78 for a pack of 3 x 10's, about PKR 51.33 per tablet. The price changed from PKR 1,467.30 to PKR 1,539.78 on 17 August 2026. Palsiwan is also available as 100 mg tablet. 5 other brands of Sertraline 50 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Palsiwan
All 5 other brands of Sertraline 50 mg tablet in Pakistan
These 5 brands are alternatives (substitutes) to Palsiwan: each contains Sertraline 50 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Obsertin (ARP (PVT) Limited) at PKR 41.77 per tablet; the highest is Reline at PKR 50.26. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Obsertin | ARP (PVT) Limited | 30s | PKR 1,253.09 | PKR 41.77 / tablet |
| Starline | Mediate Pharmaceutical Pvt Ltd | 3x10’s | PKR 1,256.92 | PKR 41.90 / tablet |
| Zesert | Bio-Labs(Pvt) Ltd | 2 x 10's | PKR 846.58 | PKR 42.33 / tablet |
| Freedep | PHARMEVO (PVT) LTD | 3 x 10's | PKR 1,353.59 | PKR 45.12 / tablet |
| Reline | Nabiqasim Industries (Pvt) Ltd | 30's | PKR 1,507.87 | PKR 50.26 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Palsiwan, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Nawan Laboratories Pvt Ltd, Karachi
- DRAP registration
- 104307
- Phone
- +92 21 35065835; +92 21 35059000
- info@nawanlab.com
- Website
- https://nawanlab.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 1,467.30 to 1,539.78 (+4.9%) between 24 Sep 2025 and 17 Aug 2026 · 2 official price records · pack 3 x 10's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Palsiwan 50 mg, 3 x 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/palsiwan-50-mg-104307-3-x-10s-nawan-laboratories-pvt-ltd/ (accessed 18 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,539.78 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 1,467.30 | 2025-09-24 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 104307Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
